[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-365155-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-365155-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","phases-of-tight-junction-barrier-disruption-during-transurothelial-migration-of-invasive-urothelial-cancer-cells","Phases of tight junction barrier disruption during transurothelial migration of invasive urothelial cancer cells","","Bladder cancer is characterized by multifocality and high recurrence, with the underlying mechanisms still incompletely understood. This study investigated transurothelial invasion as a dissemination route and sought molecules driving urothelial barrier disruption. Confocal and electron microscopy showed that within 24 hours, T24 muscle-invasive urothelial cancer cells adhere to an in vitro partially differentiated urothelial model, initiate localized tight-junction disruption, then migrate paracellularly. qPCR highlighted fibroblast activation protein (FAP)/seprase as a leading candidate; Pefabloc blocked invasion, supporting FAP/seprase as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/phases-of-tight-junction-barrier-disruption-during-transurothelial-migration-of-invasive-urothelial-cancer-cells/365155/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/phases-of-tight-junction-barrier-disruption-during-transurothelial-migration-of-invasive-urothelial-cancer-cells/365155.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What happens to tight junctions during transurothelial migration of T24 cells?","Question",{"text":63,"@type":64},"Within 24 hours, T24 cells adhere to the in vitro urothelial model and cause localized disruption of tight junctions between urothelial cells, followed by separation and paracellular migration through the urothelium.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which molecule is identified as likely involved in urothelial barrier disruption?",{"text":68,"@type":64},"qPCR analysis identified fibroblast activation protein (FAP)/seprase as the most likely candidate involved in urothelial barrier disruption.",{"name":70,"@type":61,"acceptedAnswer":71},"How does Pefabloc affect invasion by T24 cells?",{"text":72,"@type":64},"Treatment of T24 cells with Pefabloc inhibited T24 cell invasion, indicating a functional role for the tested pathway in barrier disruption and invasion.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},365155,1791195078,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":112,"preview_page_count":33,"preview_urls":145},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPhases of tight junction barrier disruption during transurothelial migration of invasive urothelial cancer cells  \nTadeja Kuret1, Mateja Erdani Kreft1, Peter Veranič1, Maja Čemažar2, Mojca Pavlin3 & Urška Dragin Jerman1􀀍  \nBladder cancer is characterised by its multifocal nature and a high recurrence, yet the underlying mechanisms of these phenomena remain only partially understood. In the present study, we aimed to investigate transurothelial invasion of urothelial cancer cells as a potential mechanism for dissemination of bladder cancer and to identify the key molecules involved in urothelial barrier disruption. Using confocal and electron microscopy, we were able to show that within a 24-hour timeframe muscle-invasive urothelial cancer cells T24 adhere to the partially differentiated normal urothelial in vitro model and initially cause localised disruption of the tight junctions between urothelial cells. Subsequently, urothelial cells separate and individual T24 cells migrate paracellularly through the urothelium. qPCR analysis identified fibroblast activation protein (FAP)/seprase as the  \ncandidate most likely to be involved in urothelial barrier disruption. In addition, treatment ofT24 cells with Pefabloc resulted in the inhibition ofT24 cell invasion. Our results contribute to the understanding of the mechanisms underlying transurothelial invasion of urothelial cancer cells. Among the molecules tested, FAP/sepraseis likely involved in cancer cell-induced disruption of the urothelial barrier, suggesting its potential as a therapeutic target to prevent progression and recurrence of bladder cancer.  \nKeywords Bladder cancer, Fibroblast activation protein, In vitro model of the urothelium, Electron microscopy, Confocal microscopy, Pefabloc  \nBladder cancer is one of the most prevalent cancers, ranking ninth in terms of global cancer diagnoses1. The disease is highly heterogeneous, characterized by a variable clinical course and a high risk of recurrence2. Bladder cancer often occurs as multifocal disease, with multiple tumor foci in the bladder detected either at initial diagnosis or after treatment, indicating recurrence3. The exact mechanisms leading to recurrence and multifocality are not yet fully understood, but two main hypotheses have been proposed4. The field cancerization theory suggests that carcinogens cause independent genetic transformations in spatially distinct urothelial cells – specialized epithelial cells that line the wall of the urinary tract, resulting in multiple, genetically unique tumors5,6. In contrast, the monoclonal theory indicates that multiple tumors arise from a single transformed cell that spreads throughout the urothelial lining, resulting in multiple, clonally related tumors. Moreover, the multifocal tumors may result from the dissemination of cancerous urothelial cells either by migration within the urothelium or by release from the primary tumor into the bladder lumen, followed by re-attachment at distant sites (intraluminal spreading)7,8. Molecular and genetic studies support both, the monoclonal origin of the tumors9 and the field cancerization theory10 although a combination of both theories is also possible. Multifocality and high recurrence are major challenges in bladder cancer management. Understanding the biological processes that contribute to these phenomena is crucial for optimizing treatment strategies and improving patient outcomes.  \nTo date, only a few studies have investigated the possible mechanisms of intraluminal spreading of urothelial cancer cells, particularly how these cells disseminate and adhere to normal urothelial cells, allowing their migration and invasion11–15. These studies suggested that alterations in the expression of cadherins, proteins that  \n1Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. 2Institute of Oncology, Ljubljana, Slov","cbCaiqGPJw2c0tBW","https://ap.wps.com/l/cbCaiqGPJw2c0tBW","pdf",3513370,12,"English","# Background\n## Multifocality and recurrence in bladder cancer\n## Competing hypotheses for tumor origin\n## Intr a luminal spreading and adhesion\n# Methods and Findings\n## In vitro urothelial model and microscopy observations\n## Identification of candidate molecules\n## Inhibition by Pefabloc","[{\"question\":\"What happens to tight junctions during transurothelial migration of T24 cells?\",\"answer\":\"Within 24 hours, T24 cells adhere to the in vitro urothelial model and cause localized disruption of tight junctions between urothelial cells, followed by separation and paracellular migration through the urothelium.\"},{\"question\":\"Which molecule is identified as likely involved in urothelial barrier disruption?\",\"answer\":\"qPCR analysis identified fibroblast activation protein (FAP)/seprase as the most likely candidate involved in urothelial barrier disruption.\"},{\"question\":\"How does Pefabloc affect invasion by T24 cells?\",\"answer\":\"Treatment of T24 cells with Pefabloc inhibited T24 cell invasion, indicating a functional role for the tested pathway in barrier disruption and invasion.\"}]","Phases of tight junction barrier disruption during transurothelial migration of invasive urothelial cancer cells | PDF",1790160204,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d922e6581798c1fa2d822d50aae28365.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7923cac945b150fbb0a9db5b869e0341.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73db290d4562f1da9fa515b5cc9f0d29.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82df511c75df3d632b710e181e2cc63e.webp",980,1287]